Update on bazedoxifene: A novel selective estrogen receptor modulator
Diane M BiskobingDepartment of Medicine, Virginia Commonwealth University, Richmond, VA, USAAbstract: In the elderly population, osteoporosis is a significant clinical problem leading to disability and even death. Many patients remain untreated, despite effective therapies, because of patients&r...
Guardado en:
Autor principal: | Diane M Biskobing |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7fc97ed35b6f49ffa5f831ab28d3fb65 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
por: Silvia Migliaccio, et al.
Publicado: (2007) -
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate H, et al.
Publicado: (2011) -
Selective estrogen receptor modulators: tissue specificity and clinical utility
por: Martinkovich S, et al.
Publicado: (2014) -
Effect of estrogens on skin aging and the potential role of SERMs
por: Susan Stevenson, et al.
Publicado: (2007) -
Rivastigmine in the treatment of Alzheimer's disease: an update
por: Maria Luisa Onor, et al.
Publicado: (2007)